ADHD patients struggle to access prescribed medications due to Schedule II restrictions and supply inconsistencies

People diagnosed with ADHD who need medications like Adderall, Vyvanse, or Ritalin face barriers accessing their prescriptions due to DEA Schedule II classification, which creates strict dispensing limits, frequent shortages, and pharmacy refusal issues. Patients and caregivers are confused about why effective treatments are heavily restricted while trying to manage their condition, and current solutions (prior authorizations, pharmacy transfers, dose adjustments) are time-consuming and often fail. This directly impacts their ability to work, study, and function daily.